OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
Niklas Frahm, Firas Fneish, David Ellenberger, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3640-3640
Open Access | Times Cited: 7
Niklas Frahm, Firas Fneish, David Ellenberger, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3640-3640
Open Access | Times Cited: 7
Showing 7 citing articles:
Global burden of vaccine‐associated multiple sclerosis, 1967–2022: A comprehensive analysis of the international pharmacovigilance database
Ho Geol Woo, Hyeon Jin Kim, Jaeyu Park, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 12
Ho Geol Woo, Hyeon Jin Kim, Jaeyu Park, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 12
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis
Katja Burian, Felicita Heidler, Niklas Frahm, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Katja Burian, Felicita Heidler, Niklas Frahm, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Era of COVID-19 in Multiple Sclerosis Care
Jonathan D. Krett, Amber Salter, Scott D. Newsome
Neurologic Clinics (2023) Vol. 42, Iss. 1, pp. 319-340
Open Access | Times Cited: 3
Jonathan D. Krett, Amber Salter, Scott D. Newsome
Neurologic Clinics (2023) Vol. 42, Iss. 1, pp. 319-340
Open Access | Times Cited: 3
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
Massimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 24-31
Open Access | Times Cited: 2
Massimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 24-31
Open Access | Times Cited: 2
COVID-19 Infection in Multiple Sclerosis Patients Treated with Rituximab Compared to Natalizumab and Healthy Controls: A Real-World Multicenter Study
Thomas Mathew, Surabhi Garg, Saji K John, et al.
Annals of Indian Academy of Neurology (2024) Vol. 27, Iss. 3, pp. 264-268
Open Access
Thomas Mathew, Surabhi Garg, Saji K John, et al.
Annals of Indian Academy of Neurology (2024) Vol. 27, Iss. 3, pp. 264-268
Open Access
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study
Firas Fneish, Niklas Frahm, Melanie Peters, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 1
Firas Fneish, Niklas Frahm, Melanie Peters, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 1
